$LPTN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Apollo Endosurgery, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Apollo Endosurgery, Inc.. Get notifications about new insider transactions in Apollo Endosurgery, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2019 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Grant | A | 0.00 | 31,250 | 0 | 292,668 | 261.4 K to 292.7 K (+11.95 %) |
Dec 31 2018 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Sell | S | 3.00 | 250,000 | 750,000 | 2,185,426 | 2.4 M to 2.2 M (-10.27 %) |
Dec 31 2018 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Sell | S | 3.00 | 250,000 | 750,000 | 2,185,426 | 2.4 M to 2.2 M (-10.27 %) |
Dec 28 2018 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Sell | S | 3.00 | 500,000 | 1,500,000 | 2,435,426 | 2.9 M to 2.4 M (-17.03 %) |
Dec 28 2018 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Sell | S | 3.00 | 500,000 | 1,500,000 | 2,435,426 | 2.9 M to 2.4 M (-17.03 %) |
Nov 21 2018 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Buy | P | 3.61 | 3,230 | 11,644 | 2,935,426 | 2.9 M to 2.9 M (+0.11 %) |
Nov 21 2018 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Buy | P | 3.40 | 54,200 | 184,280 | 2,932,196 | 2.9 M to 2.9 M (+1.88 %) |
Nov 06 2018 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Buy | P | 5.00 | 300,000 | 1,500,000 | 2,877,996 | 2.6 M to 2.9 M (+11.64 %) |
Aug 15 2018 | LPTN | Apollo Endosurgery ... | Molesphini John J | EVP, Operations | Option Exercise | A | 7.75 | 49,500 | 383,625 | 49,500 | |
Aug 15 2018 | LPTN | Apollo Endosurgery ... | Shimer Julie Ann | Director | Option Exercise | A | 7.75 | 8,002 | 62,016 | 8,002 | |
Aug 15 2018 | LPTN | Apollo Endosurgery ... | Shimer Julie Ann | Director | Grant | A | 0.00 | 2,357 | 0 | 2,357 | 0 to 2.4 K |
Jun 22 2018 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Buy | P | 5.50 | 363,500 | 1,999,250 | 417,215 | 53.7 K to 417.2 K (+676.72 %) |
Jun 22 2018 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Buy | P | 5.50 | 4,545 | 24,998 | 19,569 | 15 K to 19.6 K (+30.25 %) |
Jun 22 2018 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Buy | P | 5.50 | 72,727 | 399,999 | 268,606 | 195.9 K to 268.6 K (+37.13 %) |
Mar 13 2018 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Buy | P | 6.20 | 4,038 | 25,036 | 53,715 | 49.7 K to 53.7 K (+8.13 %) |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Option Exercise | A | 6.58 | 86,250 | 567,525 | 86,250 | |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Grant | A | 0.00 | 28,750 | 0 | 195,879 | 167.1 K to 195.9 K (+17.20 %) |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | MEELIA RICHARD J | Director | Option Exercise | A | 6.58 | 21,488 | 141,391 | 21,488 | |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | MEELIA RICHARD J | Director | Grant | A | 0.00 | 6,269 | 0 | 11,367 | 5.1 K to 11.4 K (+122.97 %) |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Option Exercise | A | 6.58 | 32,438 | 213,442 | 32,438 | |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Grant | A | 0.00 | 5,858 | 0 | 15,024 | 9.2 K to 15 K (+63.91 %) |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Option Exercise | A | 6.58 | 14,050 | 92,449 | 14,050 | |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Grant | A | 0.00 | 2,537 | 0 | 7,348 | 4.8 K to 7.3 K (+52.73 %) |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Option Exercise | A | 6.58 | 9,848 | 64,800 | 9,848 | |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Grant | A | 0.00 | 2,873 | 0 | 5,481 | 2.6 K to 5.5 K (+110.16 %) |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Option Exercise | A | 6.58 | 86,250 | 567,525 | 86,250 | |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Grant | A | 0.00 | 28,750 | 0 | 195,879 | 167.1 K to 195.9 K (+17.20 %) |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | MEELIA RICHARD J | Director | Option Exercise | A | 6.58 | 21,488 | 141,391 | 21,488 | |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | MEELIA RICHARD J | Director | Grant | A | 0.00 | 6,269 | 0 | 11,367 | 5.1 K to 11.4 K (+122.97 %) |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Option Exercise | A | 6.58 | 32,438 | 213,442 | 32,438 | |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Grant | A | 0.00 | 5,858 | 0 | 15,024 | 9.2 K to 15 K (+63.91 %) |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Option Exercise | A | 6.58 | 14,050 | 92,449 | 14,050 | |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Grant | A | 0.00 | 2,537 | 0 | 7,348 | 4.8 K to 7.3 K (+52.73 %) |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Option Exercise | A | 6.58 | 9,848 | 64,800 | 9,848 | |
Mar 02 2018 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Grant | A | 0.00 | 2,873 | 0 | 5,481 | 2.6 K to 5.5 K (+110.16 %) |
Jan 03 2018 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Buy | P | 5.78 | 6,339 | 36,656 | 2,577,996 | 2.6 M to 2.6 M (+0.25 %) |
Jan 03 2018 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Buy | P | 5.73 | 11,343 | 64,960 | 2,571,657 | 2.6 M to 2.6 M (+0.44 %) |
Jan 03 2018 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Buy | P | 5.56 | 5,163 | 28,717 | 2,560,314 | 2.6 M to 2.6 M (+0.20 %) |
Dec 28 2017 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Buy | P | 5.00 | 5,287 | 26,435 | 2,555,151 | 2.5 M to 2.6 M (+0.21 %) |
Dec 22 2017 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Buy | P | 5.00 | 41,399 | 206,863 | 2,549,864 | 2.5 M to 2.5 M (+1.65 %) |
Dec 22 2017 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Buy | P | 4.94 | 98,324 | 485,947 | 2,508,465 | 2.4 M to 2.5 M (+4.08 %) |
Dec 22 2017 | LPTN | Apollo Endosurgery ... | STONEPINE CAPITAL, L.P. | 10% Owner | Buy | P | 4.50 | 45,434 | 204,312 | 2,410,141 | 2.4 M to 2.4 M (+1.92 %) |
Dec 13 2017 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Option Exercise | A | 3.98 | 15,154 | 60,313 | 15,154 | |
Dec 13 2017 | LPTN | Apollo Endosurgery ... | Pacitti David | Director | Grant | A | 0.00 | 3,337 | 0 | 3,337 | 0 to 3.3 K |
Dec 11 2017 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | VP, US Sales & Mark ... | Option Exercise | A | 4.37 | 39,981 | 174,717 | 78,481 | |
Dec 11 2017 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | VP, US Sales & Mark ... | Grant | A | 0.00 | 13,327 | 0 | 28,958 | 15.6 K to 29 K (+85.26 %) |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Sell | J | 0.00 | 12,669 | 0 | 0 | 12.7 K to 0 (-100.00 %) |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Buy | J | 0.00 | 12,669 | 0 | 12,669 | 0 to 12.7 K |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Sell | J | 0.00 | 1,266,909 | 0 | 0 | 1.3 M to 0 (-100.00 %) |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | Anderson Rick D | Director | Buy | J | 0.00 | 4,223 | 0 | 49,677 | 45.5 K to 49.7 K (+9.29 %) |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | Anderson Rick D | Director | Sell | J | 0.00 | 12,669 | 0 | 0 | 12.7 K to 0 (-100.00 %) |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | Anderson Rick D | Director | Buy | J | 0.00 | 12,669 | 0 | 12,669 | 0 to 12.7 K |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | Anderson Rick D | Director | Sell | J | 0.00 | 1,266,909 | 0 | 0 | 1.3 M to 0 (-100.00 %) |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Buy | J | 0.00 | 4,223 | 0 | 49,677 | 45.5 K to 49.7 K (+9.29 %) |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Sell | J | 0.00 | 12,669 | 0 | 0 | 12.7 K to 0 (-100.00 %) |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Buy | J | 0.00 | 12,669 | 0 | 12,669 | 0 to 12.7 K |
Nov 30 2017 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Sell | J | 0.00 | 1,266,909 | 0 | 0 | 1.3 M to 0 (-100.00 %) |
Nov 09 2017 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | V.P. U.S. Sales and ... | Buy | P | 4.24 | 9,500 | 40,280 | 15,631 | 6.1 K to 15.6 K (+154.95 %) |
Sep 25 2017 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Buy | P | 3.85 | 135,000 | 519,750 | 1,266,909 | 1.1 M to 1.3 M (+11.93 %) |
Sep 25 2017 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Buy | P | 4.04 | 41,000 | 165,640 | 1,131,909 | 1.1 M to 1.1 M (+3.76 %) |
Sep 25 2017 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Buy | P | 3.85 | 135,000 | 519,750 | 1,266,909 | 1.1 M to 1.3 M (+11.93 %) |
Sep 25 2017 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Buy | P | 4.04 | 41,000 | 165,640 | 1,131,909 | 1.1 M to 1.1 M (+3.76 %) |
Sep 25 2017 | LPTN | Apollo Endosurgery ... | Anderson Rick D | Director | Buy | P | 3.85 | 135,000 | 519,750 | 1,266,909 | 1.1 M to 1.3 M (+11.93 %) |
Sep 25 2017 | LPTN | Apollo Endosurgery ... | Anderson Rick D | Director | Buy | P | 4.04 | 41,000 | 165,640 | 1,131,909 | 1.1 M to 1.1 M (+3.76 %) |
Sep 19 2017 | LPTN | Apollo Endosurgery ... | McWilliams Dennis L. | President, CCO | Option Exercise | X | 1.76 | 28,757 | 50,612 | 0 | |
Sep 19 2017 | LPTN | Apollo Endosurgery ... | McWilliams Dennis L. | President, CCO | Buy | X | 1.76 | 28,757 | 50,612 | 62,404 | 33.6 K to 62.4 K (+85.47 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | PTV SCIENCES II L P | 10% Owner | Buy | P | 5.50 | 1,090,909 | 6,000,000 | 5,243,372 | 4.2 M to 5.2 M (+26.27 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Novo Holdings A/S | 10% Owner | Sell | S | 6.84 | 8,426 | 57,643 | 1,301,842 | 1.3 M to 1.3 M (-0.64 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Novo Holdings A/S | 10% Owner | Sell | S | 6.96 | 24,504 | 170,585 | 1,310,268 | 1.3 M to 1.3 M (-1.84 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Novo Holdings A/S | 10% Owner | Sell | S | 6.83 | 17,200 | 117,538 | 1,334,772 | 1.4 M to 1.3 M (-1.27 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Anderson Rick D | Director | Buy | P | 5.50 | 1,090,909 | 6,000,000 | 1,090,909 | 0 to 1.1 M |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Anderson Rick D | Director | Buy | P | 5.50 | 45,454 | 249,997 | 45,454 | 0 to 45.5 K |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Buy | P | 5.50 | 1,090,909 | 6,000,000 | 1,090,909 | 0 to 1.1 M |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Crawford Matthew S | Director | Buy | P | 5.50 | 45,454 | 249,997 | 45,454 | 0 to 45.5 K |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | MEELIA RICHARD J | Director | Buy | P | 5.50 | 45,454 | 249,997 | 45,454 | 0 to 45.5 K |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Director | Buy | P | 5.50 | 273,770 | 1,505,735 | 469,100 | 195.3 K to 469.1 K (+140.16 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Director | Buy | P | 5.50 | 78,965 | 434,308 | 400,675 | 321.7 K to 400.7 K (+24.55 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Director | Buy | P | 5.50 | 12,548 | 69,014 | 63,671 | 51.1 K to 63.7 K (+24.54 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Director | Buy | P | 5.50 | 80,276 | 441,518 | 293,309 | 213 K to 293.3 K (+37.68 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | McGaughy R Kent Jr | Director | Buy | P | 5.50 | 8,986 | 49,423 | 45,594 | 36.6 K to 45.6 K (+24.55 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Buy | P | 5.50 | 4,545 | 24,998 | 9,166 | 4.6 K to 9.2 K (+98.36 %) |
Jul 26 2017 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Buy | P | 5.50 | 136,363 | 749,997 | 167,129 | 30.8 K to 167.1 K (+443.23 %) |
May 30 2017 | LPTN | Apollo Endosurgery ... | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Grant | A | 0.00 | 1,757 | 0 | 4,621 | 2.9 K to 4.6 K (+61.35 %) |
May 30 2017 | LPTN | Apollo Endosurgery ... | MEELIA RICHARD J | Director | Option Exercise | J | 6.50 | 9,468 | 61,542 | 9,468 | |
May 30 2017 | LPTN | Apollo Endosurgery ... | MEELIA RICHARD J | Director | Option Exercise | J | 3.36 | 5,751 | 19,323 | 5,751 | |
May 30 2017 | LPTN | Apollo Endosurgery ... | MEELIA RICHARD J | Director | Option Exercise | J | 2.09 | 9,202 | 19,232 | 9,202 | |
May 30 2017 | LPTN | Apollo Endosurgery ... | MEELIA RICHARD J | Director | Buy | J | 1.36 | 17,501 | 23,801 | 17,501 | 0 to 17.5 K |
May 30 2017 | LPTN | Apollo Endosurgery ... | MEELIA RICHARD J | Director | Grant | A | 0.00 | 5,098 | 0 | 5,098 | 0 to 5.1 K |
May 30 2017 | LPTN | Apollo Endosurgery ... | Tribie Charles | Exec VP of Ops | Grant | A | 0.00 | 894 | 0 | 894 | 0 to 894 |
May 30 2017 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | VP, US Sales & Mark ... | Option Exercise | J | 6.50 | 15,495 | 100,718 | 15,495 | |
May 30 2017 | LPTN | Apollo Endosurgery ... | Schwartzhoff Bret | VP, US Sales & Mark ... | Grant | A | 0.00 | 6,131 | 0 | 6,131 | 0 to 6.1 K |
May 30 2017 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Option Exercise | J | 6.50 | 4,844 | 31,486 | 4,844 | |
May 30 2017 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Grant | A | 0.00 | 2,608 | 0 | 2,608 | 0 to 2.6 K |
May 18 2017 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Buy | P | 6.42 | 1,200 | 7,704 | 2,000 | 800 to 2 K (+150.00 %) |
May 18 2017 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Buy | P | 6.18 | 500 | 3,090 | 800 | 300 to 800 (+166.67 %) |
May 18 2017 | LPTN | Apollo Endosurgery ... | McClellan William D. Jr. | Director | Buy | P | 6.19 | 300 | 1,857 | 300 | 0 to 300 |
May 18 2017 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Buy | P | 6.35 | 822 | 5,220 | 30,766 | 29.9 K to 30.8 K (+2.75 %) |
May 18 2017 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Buy | P | 6.19 | 400 | 2,476 | 29,944 | 29.5 K to 29.9 K (+1.35 %) |
May 18 2017 | LPTN | Apollo Endosurgery ... | Newton Todd | Chief Executive Off ... | Buy | P | 6.12 | 899 | 5,502 | 29,544 | 28.6 K to 29.5 K (+3.14 %) |
May 11 2017 | LPTN | Apollo Endosurgery ... | Novo A/S | 10% Owner | Sell | S | 5.62 | 103,500 | 582,094 | 1,351,972 | 1.5 M to 1.4 M (-7.11 %) |
May 11 2017 | LPTN | Apollo Endosurgery ... | Novo A/S | 10% Owner | Sell | S | 5.74 | 1,500 | 8,609 | 1,455,472 | 1.5 M to 1.5 M (-0.10 %) |
Feb 17 2017 | LPTN | Apollo Endosurgery ... | Gostout Christopher J. | Chief Medical Offic ... | Option Exercise | A | 11.76 | 135,000 | 1,587,600 | 135,000 | |
Dec 30 2016 | LPTN | LPATH, INC | Anderson Rick D | Director | Buy | J | 0.00 | 605,712 | 0 | 605,712 | 0 to 605.7 K |
Dec 30 2016 | LPTN | LPATH, INC | Anderson Rick D | Director | Buy | J | 0.00 | 2,199,186 | 0 | 2,199,186 | 0 to 2.2 M |
Dec 30 2016 | LPTN | LPATH, INC | Anderson Rick D | Director | Buy | J | 0.00 | 1,347,565 | 0 | 1,347,565 | 0 to 1.3 M |
Dec 30 2016 | LPTN | LPATH, INC | Crawford Matthew S | Director | Buy | J | 0.00 | 605,712 | 0 | 605,712 | 0 to 605.7 K |
Dec 30 2016 | LPTN | LPATH, INC | Crawford Matthew S | Director | Buy | J | 0.00 | 2,199,186 | 0 | 2,199,186 | 0 to 2.2 M |
Dec 30 2016 | LPTN | LPATH, INC | Crawford Matthew S | Director | Buy | J | 0.00 | 1,347,565 | 0 | 1,347,565 | 0 to 1.3 M |
Dec 30 2016 | LPTN | LPATH, INC | Creecy John W | Director | Buy | J | 0.00 | 1,309,392 | 0 | 1,309,392 | 0 to 1.3 M |
Dec 30 2016 | LPTN | LPATH, INC | McClellan William D. Jr. | Director | Option Exercise | J | 3.36 | 1,437 | 4,828 | 1,437 | |
Dec 30 2016 | LPTN | LPATH, INC | McGaughy R Kent Jr | Director | Buy | J | 0.00 | 195,330 | 0 | 195,330 | 0 to 195.3 K |
Dec 30 2016 | LPTN | LPATH, INC | McGaughy R Kent Jr | Director | Buy | J | 0.00 | 321,710 | 0 | 321,710 | 0 to 321.7 K |
Dec 30 2016 | LPTN | LPATH, INC | McGaughy R Kent Jr | Director | Buy | J | 0.00 | 51,123 | 0 | 51,123 | 0 to 51.1 K |
Dec 30 2016 | LPTN | LPATH, INC | McGaughy R Kent Jr | Director | Buy | J | 0.00 | 213,033 | 0 | 213,033 | 0 to 213 K |
Dec 30 2016 | LPTN | LPATH, INC | McGaughy R Kent Jr | Director | Buy | J | 0.00 | 36,608 | 0 | 36,608 | 0 to 36.6 K |
Dec 30 2016 | LPTN | LPATH, INC | MEELIA RICHARD J | Director | Option Exercise | J | 3.36 | 5,751 | 19,323 | 5,751 | |
Dec 30 2016 | LPTN | LPATH, INC | MEELIA RICHARD J | Director | Option Exercise | J | 2.09 | 9,202 | 19,232 | 9,202 | |
Dec 30 2016 | LPTN | LPATH, INC | MEELIA RICHARD J | Director | Buy | J | 0.00 | 17,501 | 0 | 17,501 | 0 to 17.5 K |
Dec 30 2016 | LPTN | LPATH, INC | Robertson Bruce C | Director | Buy | J | 0.00 | 1,451,185 | 0 | 1,451,185 | 0 to 1.5 M |
Dec 30 2016 | LPTN | LPATH, INC | PTV SCIENCES II L P | 10% Owner | Buy | J | 0.00 | 605,712 | 0 | 605,712 | 0 to 605.7 K |
Dec 30 2016 | LPTN | LPATH, INC | PTV SCIENCES II L P | 10% Owner | Buy | J | 0.00 | 2,199,186 | 0 | 2,199,186 | 0 to 2.2 M |
Dec 30 2016 | LPTN | LPATH, INC | PTV SCIENCES II L P | 10% Owner | Buy | J | 0.00 | 1,347,565 | 0 | 1,347,565 | 0 to 1.3 M |
Dec 30 2016 | LPTN | LPATH, INC | Remeditex Ventures LLC | 10% Owner | Buy | J | 0.00 | 1,309,392 | 0 | 1,309,392 | 0 to 1.3 M |
Dec 30 2016 | LPTN | LPATH, INC | H.I.G. Ventures - Endosurgery, ... | 10% Owner | Buy | J | 0.00 | 1,451,185 | 0 | 1,451,185 | 0 to 1.5 M |
Dec 29 2016 | LPTN | LPATH, INC | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Option Exercise | J | 3.36 | 37,384 | 125,610 | 37,384 | |
Dec 29 2016 | LPTN | LPATH, INC | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Option Exercise | J | 1.76 | 8,627 | 15,184 | 8,627 | |
Dec 29 2016 | LPTN | LPATH, INC | Cavanaugh Stefanie L. | CFO, Treasurer, Sec ... | Buy | J | 0.00 | 2,864 | 0 | 2,864 | 0 to 2.9 K |
Dec 29 2016 | LPTN | LPATH, INC | Tribie Charles | Executive V.P. of O ... | Option Exercise | J | 1.76 | 8,627 | 15,184 | 8,627 | |
Dec 29 2016 | LPTN | LPATH, INC | Tribie Charles | Executive V.P. of O ... | Option Exercise | J | 1.76 | 8,627 | 15,184 | 8,627 | |
Dec 29 2016 | LPTN | LPATH, INC | Tribie Charles | Executive V.P. of O ... | Option Exercise | J | 3.36 | 56,018 | 188,220 | 56,018 | |
Dec 29 2016 | LPTN | LPATH, INC | McWilliams Dennis L. | President, CCO | Option Exercise | J | 1.76 | 28,757 | 50,612 | 28,757 | |
Dec 29 2016 | LPTN | LPATH, INC | McWilliams Dennis L. | President, CCO | Option Exercise | J | 3.36 | 27,404 | 92,077 | 27,404 | |
Dec 29 2016 | LPTN | LPATH, INC | McWilliams Dennis L. | President, CCO | Option Exercise | J | 3.36 | 54,808 | 184,155 | 54,808 | |
Dec 29 2016 | LPTN | LPATH, INC | McWilliams Dennis L. | President, CCO | Option Exercise | J | 2.09 | 109,851 | 229,589 | 109,851 | |
Dec 29 2016 | LPTN | LPATH, INC | McWilliams Dennis L. | President, CCO | Option Exercise | J | 1.76 | 28,757 | 50,612 | 28,757 | |
Dec 29 2016 | LPTN | LPATH, INC | McWilliams Dennis L. | President, CCO | Buy | J | 0.00 | 33,647 | 0 | 33,647 | 0 to 33.6 K |
Dec 29 2016 | LPTN | LPATH, INC | Newton Todd | Chief Executive Off ... | Option Exercise | J | 3.36 | 112,109 | 376,686 | 112,109 | |
Dec 29 2016 | LPTN | LPATH, INC | Newton Todd | Chief Executive Off ... | Option Exercise | J | 3.36 | 261,587 | 878,932 | 261,587 | |
Dec 29 2016 | LPTN | LPATH, INC | Newton Todd | Chief Executive Off ... | Buy | J | 0.00 | 28,645 | 0 | 28,645 | 0 to 28.6 K |
Dec 29 2016 | LPTN | LPATH, INC | Schwartzhoff Bret | V.P. U.S. Sales and ... | Option Exercise | J | 1.76 | 11,502 | 20,244 | 11,502 | |
Dec 29 2016 | LPTN | LPATH, INC | Schwartzhoff Bret | V.P. U.S. Sales and ... | Option Exercise | J | 3.36 | 23,005 | 77,297 | 23,005 | |
Mar 16 2016 | LPTN | LPATH, INC | Swortwood Donald | Director | Option Exercise | M | 0.00 | 3,485 | 0 | 0 | |
Mar 16 2016 | LPTN | LPATH, INC | Swortwood Donald | Director | Buy | M | 0.00 | 3,485 | 0 | 9,200 | 5.7 K to 9.2 K (+60.98 %) |
Mar 16 2016 | LPTN | LPATH, INC | Petree Daniel H | Director | Option Exercise | M | 0.00 | 4,646 | 0 | 0 | |
Mar 16 2016 | LPTN | LPATH, INC | Petree Daniel H | Director | Buy | M | 0.00 | 4,646 | 0 | 11,155 | 6.5 K to 11.2 K (+71.38 %) |
Mar 16 2016 | LPTN | LPATH, INC | MATHEWS CHARLES | Director | Option Exercise | M | 0.00 | 3,485 | 0 | 0 | |
Mar 16 2016 | LPTN | LPATH, INC | MATHEWS CHARLES | Director | Buy | M | 0.00 | 3,485 | 0 | 19,916 | 16.4 K to 19.9 K (+21.21 %) |
Mar 16 2016 | LPTN | LPATH, INC | Ferrell Jeffrey | Director | Option Exercise | M | 0.00 | 3,485 | 0 | 0 | |
Mar 16 2016 | LPTN | LPATH, INC | Ferrell Jeffrey | Director | Buy | M | 0.00 | 3,485 | 0 | 12,486 | 9 K to 12.5 K (+38.72 %) |
Mar 16 2016 | LPTN | LPATH, INC | Atkinson Gary J G | CEO and CFO | Option Exercise | M | 0.00 | 9,500 | 0 | 0 |